Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab with Cisplatin and Gemcitabine in Metastatic Transitional Cell Cancer
NCT00234494Phase 2Completed
- Start
- Nov 2005
- Primary completion
- Dec 2008
- Countries
- 1
01
Overview
Phase 2, open-label trial of bevacizumab in bladder transitional cell carcinoma (TCC). Started Nov 2005; status: completed.
02
Drugs
bevacizumab
03
Conditions
bladder transitional cell carcinoma (TCC)
Beyond the preview
Go deeper on NCT00234494.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00234494.